NeuroOne Medical Statistics
Share Statistics
NeuroOne Medical has 47.39M
shares outstanding. The number of shares has increased by 10.85%
in one year.
| Shares Outstanding | 47.39M |
| Shares Change (YoY) | 10.85% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | 6.05% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 407.14K, so 0.86% of the outstanding
shares have been sold short.
| Short Interest | 407.14K |
| Short % of Shares Out | 0.86% |
| Short % of Float | 0.88% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.15 and the forward
PE ratio is -3.43.
NeuroOne Medical's PEG ratio is
0.07.
| PE Ratio | -2.15 |
| Forward PE | -3.43 |
| PS Ratio | 7.67 |
| Forward PS | 1.9 |
| PB Ratio | 32.23 |
| P/FCF Ratio | -2.38 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for NeuroOne Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09,
with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.09 |
| Quick Ratio | 0.9 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | -51.91 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $203,117.82 |
| Profits Per Employee | $-724,594.71 |
| Employee Count | 17 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 0.9 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -47.01% in the
last 52 weeks. The beta is 0.69, so NeuroOne Medical's
price volatility has been higher than the market average.
| Beta | 0.69 |
| 52-Week Price Change | -47.01% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 45.2 |
| Average Volume (20 Days) | 289,259 |
Income Statement
In the last 12 months, NeuroOne Medical had revenue of 3.45M
and earned -12.32M
in profits. Earnings per share was -0.46.
| Revenue | 3.45M |
| Gross Profit | 1.08M |
| Operating Income | -11.89M |
| Net Income | -12.32M |
| EBITDA | -11.84M |
| EBIT | -12.09M |
| Earnings Per Share (EPS) | -0.46 |
Full Income StatementBalance Sheet
The company has 1.46M in cash and 260.16K in
debt, giving a net cash position of 1.2M.
| Cash & Cash Equivalents | 1.46M |
| Total Debt | 260.16K |
| Net Cash | 1.2M |
| Retained Earnings | -75M |
| Total Assets | 6.49M |
| Working Capital | 4.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -11.01M
and capital expenditures -120.2K, giving a free cash flow of -11.13M.
| Operating Cash Flow | -11.01M |
| Capital Expenditures | -120.2K |
| Free Cash Flow | -11.13M |
| FCF Per Share | -0.42 |
Full Cash Flow StatementMargins
Gross margin is 31.27%, with operating and profit margins of -344.26% and -356.74%.
| Gross Margin | 31.27% |
| Operating Margin | -344.26% |
| Pretax Margin | -356.74% |
| Profit Margin | -356.74% |
| EBITDA Margin | -342.96% |
| EBIT Margin | -344.26% |
| FCF Margin | -322.39% |
